Effectiveness, Satisfaction, and Usability of Virtual Reality in the Management of Postoperative Pain in Patients Undergoing Knee Arthroplasty

December 3, 2025 updated by: Universidad Francisco de Vitoria

The goal of this clinical trial is to evaluate the effectiveness of using virtual reality glasses to reduce the need for rescue analgesia in patients with acute postoperative pain after knee arthroplasty.

The main questions it aims to answer are:

  • What is the impact of virtual reality use on postoperative pain perception as measured by the Visual Analogue Scale (VAS)?
  • What potential adverse effects are associated with the use of virtual reality in the postoperative context?
  • What is the level of satisfaction and acceptance of virtual reality as a complementary strategy for pain management?
  • How does virtual reality influence quality of life and psychosocial variables in patients with acute postoperative pain after knee arthroplasty?

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

A single-blind, randomized controlled trial will be conducted to compare gaming, 360° video viewing, and usual care interventions. Participants will be recruited from the prehabilitation clinic at Hospital del Sureste (Arganda del Rey), and the study will follow the CONSORT guidelines for clinical crossover and parallel trials.

Three experimental groups will be tested, with interventions performed at three different time points during hospitalization, each session lasting between 10 and 30 minutes. The gaming group will play video games, the control group will view 360° videos, and the usual care group will receive standard analgesia according to the protocol.

Outcome measures will be assessed at baseline (3 months before the intervention), during the intervention, and 1 month after the intervention.

Study Type

Interventional

Enrollment (Estimated)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults ≥18 years of age, both sexes
  • Scheduled unilateral knee arthroplasty
  • Adequate cognitive and functional capacity to use virtual reality
  • Signed informed consent

Exclusion Criteria:

  • Neurological or psychiatric disorders (history of epilepsy, seizures, psychosis, schizophrenia, claustrophobia, tremor, rigidity)
  • Significant visual or hearing impairments that hinder VR use
  • Physical or motor limitations preventing the use of VR headsets or maintaining the required posture
  • Score ≥4 on the 4AT delirium screening tool
  • Pregnancy
  • Recreational drug or alcohol use
  • Inability to complete the intervention protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: CONTROL
CONVENTIONAL TREATMENT
Experimental: EXPERIMENTAL
VR GAMES

Interactive VR Games: Participants use Meta Quest 3 head-mounted displays running a custom-developed VR application designed to elicit upper-limb and trunk movements. The application includes multiple structured scenarios:

  • Scenario 1 (Painting): Participants perform arm movements using handheld controllers to interact with a virtual painting environment.
  • Scenario 2 (Greenhouse): Participants move the arm to attract a butterfly, guide it toward a flower, and complete the assigned interaction task.
  • Scenario 3 (Aquarium): Participants perform bilateral arm movements to pop virtual bubbles.

Immersive 360° Videos:Participants use Meta Quest 3 head-mounted displays to view immersive 360° relaxing videos (e.g., natural landscapes accompanied by calming background music).

Placebo Comparator: PLACEBO
VR VIDEOS 360º

Interactive VR Games: Participants use Meta Quest 3 head-mounted displays running a custom-developed VR application designed to elicit upper-limb and trunk movements. The application includes multiple structured scenarios:

  • Scenario 1 (Painting): Participants perform arm movements using handheld controllers to interact with a virtual painting environment.
  • Scenario 2 (Greenhouse): Participants move the arm to attract a butterfly, guide it toward a flower, and complete the assigned interaction task.
  • Scenario 3 (Aquarium): Participants perform bilateral arm movements to pop virtual bubbles.

Immersive 360° Videos:Participants use Meta Quest 3 head-mounted displays to view immersive 360° relaxing videos (e.g., natural landscapes accompanied by calming background music).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity (VAS)
Time Frame: Day 0 (day of intervention): pain measured at arrival to the ward and during three shifts (morning, afternoon, next-day morning), pre- and post conventional analgesia. If VR is used, pain is also measured immediately before and after each VR session.
Pain intensity is assessed using a 100-mm Visual Analogue Scale (VAS), ranging from "no pain" (0 mm, left anchor) to "worst imaginable pain" (100 mm, right anchor). Higher scores indicate greater pain intensity.
Day 0 (day of intervention): pain measured at arrival to the ward and during three shifts (morning, afternoon, next-day morning), pre- and post conventional analgesia. If VR is used, pain is also measured immediately before and after each VR session.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sociodemographic variables
Time Frame: Baseline
Age, weight, sex, and height recorded at enrollment
Baseline
Analgesic medication use
Time Frame: From immediate postoperative period to 48 hours post-intervention.
Analgesic administration (scheduled analgesia and rescue medication) is extracted from the hospital electronic medical record (Selene). Date and time of each dose are recorded to determine whether the intervention reduces short-term analgesic requirements.
From immediate postoperative period to 48 hours post-intervention.
Adverse events
Time Frame: Throughout the intervention period and up to 48 hours post-intervention.
All adverse events reported by participants or investigators are documented and classified by intensity ("mild," "moderate," "severe") and by relatedness to the intervention ("none," "unlikely," "possible," "definite")
Throughout the intervention period and up to 48 hours post-intervention.
Satisfaction, Acceptability, and Perceived Safety (SEQ)
Time Frame: Immediately post-intervention
The Suitability Evaluation Questionnaire (SEQ) assesses satisfaction, acceptability, usability, and perceived safety of the VR system. It includes 13 items rated from 1 ("not at all" or "very easy") to 5 ("very much" or "very difficult"), plus one open-ended question on discomfort
Immediately post-intervention
Health-Related Quality of Life (EQ-5D-5L)
Time Frame: Baseline and 1-month follow-up during outpatient visit
The EQ-5D-5L assesses mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each rated on a 5-level severity scale. Provides an individual health profile and utility index
Baseline and 1-month follow-up during outpatient visit
Anxiety and depression (Goldberg Anxiety and Depression Scale)
Time Frame: Baseline and 1-month follow-up during outpatient visit
The Goldberg Scale screens symptoms of anxiety and depression to explore changes associated with the intervention.
Baseline and 1-month follow-up during outpatient visit
Physical Activity Level (IPAQ)
Time Frame: Baseline and 1-month follow-up during outpatient visit
The International Physical Activity Questionnaire (IPAQ) assesses duration, frequency, and intensity of physical activity in the previous week, categorizing participants into low, moderate, or high activity levels.
Baseline and 1-month follow-up during outpatient visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 27, 2025

Primary Completion (Estimated)

December 30, 2025

Study Completion (Estimated)

December 30, 2026

Study Registration Dates

First Submitted

December 3, 2025

First Submitted That Met QC Criteria

December 3, 2025

First Posted (Actual)

December 16, 2025

Study Record Updates

Last Update Posted (Actual)

December 16, 2025

Last Update Submitted That Met QC Criteria

December 3, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Arthroplasty

Clinical Trials on VIRTUAL REALITY

Subscribe